Home › Speech Sound Disorder › NCT06416306

Treatment Targets in Spanish and English Bilingual Speech Intervention

Speech Intervention for Bilingual Children

Who can join

Ages 3 to 8 · All sexes

Inclusion Criteria:

* Participants will be regularly exposed to English for at least 3 months in one of the following ways: a) an English-speaking caregiver or sibling who interacts with the child on a daily basis in English, b) attendance at an English-speaking daycare, preschool, or elementary school.
* Caregivers will have reported concern with their child's speech development and/or reduced intelligibility on the Intelligibility in Context Scale in Spanish or English.
* Participants will present with 5 or more consonants or clusters missing from their phonetic inventories in each language to confirm presence of a speech sound disorder and sufficient gaps in phonological knowledge to warrant treatment.

Exclusion Criteria:

* Participants receiving speech or language treatment elsewhere during their participation in this project.

About the study

The goal of this clinical trial is to learn which speech treatment targets result in the greatest amount of speech learning in Spanish-English bilingual children with speech sound disorders. The main questions it aims to answer are:

* Does linguistic complexity of the treatment target increase the amount of generalized learning within the treated language? * Does linguistic complexity of the treatment target increase the amount of generalized speech across languages?

Researchers will compare intervention effects across treatment provided in English and Spanish to see if the effect differs according to the language of intervention.

Participants will:

* Attend between 12 and 18 45-minute speech intervention sessions in Spanish or English for up to 6 weeks * Attend assessment visits before and after intervention * Attend follow-up assessment visits 1 month and 2 months after intervention

What is being tested

• Speech Intervention (behavioral)

Sponsor: Philip Combiths · Participants: 16 · Started: May 8, 2024

Contact the study team

• Philip Combiths · Phone: 3194674432

Official record on ClinicalTrials.gov — NCT06416306

Locations in the U.S.

Conditions

• Speech Sound Disorder

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.